PD-L1 Testing in Cancer: IHC Scores and Result Interpretation
Understand what PD-L1 IHC measures, how TPS, CPS and immune-cell scores are calculated, and why results must be interpreted by your oncology team.
Written byTeam Oncquest
Reviewer
Reviewer profile
Dr. Monica Verma
Dr. Monica Verma is Head of Surgical Pathology at Oncquest Laboratories.
1
Articles reviewedof 11 in the library
1
Topic coveredAcross published contributions
Oct 242026
Latest article updatePublished content
About
Background
Dr. Monica Verma is Head of Surgical Pathology at Oncquest Laboratories. She holds MBBS and MD qualifications and has over 25 years of experience in Histopathology and Immunohistochemistry. She completed her graduate, postgraduate and Senior Residency training at Lady Hardinge Medical College, New Delhi. She is an NABL Assessor and CAP Team Leader Trainee, with expertise in diagnostic pathology and laboratory quality systems. Her areas of interest include gastrointestinal and liver, breast, gynaecological and uro-genital pathology.
Topics covered
Review record
Reviewed Articles 1
1 article.